Ancient organism, modern immunity

The adaptive immune system, which can recognize, attack, and remember potentially harmful microbes, may have appeared on the evolutionary scene millions of years earlier than scientists thought. The immune system of the sea lamprey, a primitive, jawless fish, contains two cell types that recognize and respond to characteristic molecules associated with invading pathogens, researchers report in this week's __Nature__. "It's amazing to us," lead author linkurl:Max Cooper,;http://www.gra.org/Emine

Written byBob Grant
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
The adaptive immune system, which can recognize, attack, and remember potentially harmful microbes, may have appeared on the evolutionary scene millions of years earlier than scientists thought. The immune system of the sea lamprey, a primitive, jawless fish, contains two cell types that recognize and respond to characteristic molecules associated with invading pathogens, researchers report in this week's __Nature__. "It's amazing to us," lead author linkurl:Max Cooper,;http://www.gra.org/EminentScholarsDetail/tabid/368/xmmid/1072/xmid/377/xmview/2/school/Emory%20University/Default.aspx an immunologist at Emory University in Atlanta, told __The Scientist__. "We never anticipated it."
The lamprey's imposing (but jawless) mouth
Image: US Environmental Protection Agency
Organisms such as plants and invertebrates have innate immune systems, which protect against pathogens in a nonspecific manner. More highly derived organisms such as mammals, however, also have adaptive immune systems, which can mount a two-pronged attack against foreign invaders. Adaptive immunity consists of humoral defenses, where B lymphocytes secrete antibodies against specific antigens, and cellular defenses, in which a host of T lymphocytes mediate a complex cellular attack. Scientists had previously identified cartilaginous fishes such as sharks, skates and rays as the most ancient possessors of this two-pronged adaptive immune system -- likely an evolutionary precursor to the mammalian adaptive immune system. The presence of adaptive immunity in lampreys, however, whose ancestors diverged from other vertebrates some 500 million years ago, means the general strategy is significantly older. Using a panel of monoclonal and polyclonal antibodies and challenges with bacterial antigens and human cells, Cooper and his team found that two lymphocyte types in lampreys had very different receptor repertoires and behaved similarly to the T and B cells of the mammalian adaptive immune system. Lampreys have one type of variable lymphocyte receptor (VLRA) that, like T cells, upregulates the expression of specific cytokine genes and inhibitory factors in response to antigens, and another receptor (VLRB) that, like B cells, binds native antigens and produces antibodies. VLRA and VLRB receptors were expressed by distinct lymphocyte populations, and the gene expression profiles for each type of cell resembled those of mammalian T and B cells. "The finding is amazingly interesting because either it shows that there's some kind of deep homology between these cell types or that there's some kind of convergent evolution," University of Toronto immunologist linkurl:Jonathan Rast,;http://medbio.utoronto.ca/faculty/rast.html who was not involved in the study, told __The Scientist__. "It's hard to know if the lampreys were the first jawless vertebrates to show this system," Brantley Herrin, Cooper's postdoc and coauthor on the paper, told __The Scientist__. He noted that Cooper's lab linkurl:reported;http://www.nature.com/ni/journal/v9/n3/abs/ni1562.html last year that the lamprey's VLRB cells behaved similarly to mammalian B cells. But the latest findings "suggest that there was an earlier division between humoral and cellular immunity than previously anticipated," Herrin said. The evolutionary rudiments of the human adaptive immune system could have first appeared in an even more ancient jawed fish whose existence has yet to be revealed in the fossil record, he added. Cooper noted that the lamprey system he and his colleagues described is likely an example of convergent evolution -- where distinct lineages evolve similar traits along distinct evolutionary paths -- rather than being an early version of the mammalian immune system. Rast agreed. "It's probably safer to treat [the lamprey VLR cells] as non-homologous until it's proven that they are," he said. Interestingly, lampreys lack a detectable spleen or thymus, which in jawed vertebrates serve as the sites for B cell and T cell maturation, respectively. Cooper said that his lab, in collaboration with others, is now turning to the search for thymus-like tissues in the lamprey. In their 2008 linkurl:study,;http://www.nature.com/ni/journal/v9/n3/abs/ni1562.html Cooper's lab reported that the lamprey's B-cell-like lymphocytes (VLRBs) were likely generated in an invagination near the intestine called the typhlosole. "Now there are lots of tools that can be used to go back and reexamine the question," said Cooper, adding that he and his colleagues plan to use chemokines and cytokines to molecularly probe for thymus-like tissues in the lamprey. "It will be very interesting to find out if there's something analogous" to the thymus in lampreys, said Rast. "Ten years ago, you really couldn't do anything outside of the jawed vertebrates," he added, but with the genomes of several invertebrate species and that of lampreys set for publication soon, the power to study immunology in a wider range of organisms is growing. "It's a really exciting time," Rast said. "Immunology is really going to expand."
**__Related stories:__***linkurl:Fish virus hits Great Lakes;http://www.the-scientist.com/news/display/53252/
[24th May 2007]*linkurl:Lamprey immunity;http://www.the-scientist.com/article/display/43705/
[February 2007]*linkurl:Evolution of innate immunity;http://www.the-scientist.com/article/display/22271/
[8th July 2004] __Editor's note (June 1): This article has been updated from a previous version.__
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies